Skip to the page

Data / Drug companies / Macrolide

Macrolide drugs: 5 drugs from 44 companies in the FDA NDC directory

Macrolide is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 109 products in this class from 44 companies, covering 5 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on August 13, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

  • 44Companies
  • 109Products
  • 5Drugs by generic name

Drugs in the Macrolide class

Ranked by number of companies that list the drug.

DrugProducts hereCompanies listing it
Erythromycin8136
Erythromycin ethylsuccinate228
Erythromycin lactobionate44
Erythromycin and benzoyl peroxide13
Erythromycin topical solution 2%11

Companies with the most products in this class

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Azurity Pharmaceuticals, Inc.12tablet, delayed release; suspensionGeneric drugs (ANDA)June 14, 2012
Wilshire Pharmaceuticals, Inc.9tablet, delayed release; suspensionGeneric drugs (ANDA)August 24, 2020
Amneal Pharmaceuticals NY LLC5tablet, delayed release; suspensionGeneric drugs (ANDA)November 4, 2019
Bryant Ranch Prepack5for suspension; solutionGeneric drugs (ANDA)November 21, 2022
Torrent Pharmaceuticals Limited5tablet, delayed release; tablet, coatedGeneric drugs (ANDA)October 21, 2024
Cadila Pharmaceuticals Limited4tablet, film coated; for suspensionGeneric drugs (ANDA)November 21, 2022
Golden State Medical Supply, Inc.4tablet, coated; tablet, delayed releaseGeneric drugs (ANDA)July 26, 2021
NuCare Pharmaceuticals,Inc.4ointment; solutionGeneric drugs (ANDA)October 18, 2023
A-S Medication Solutions3ointment; tablet, film coatedGeneric drugs (ANDA)May 4, 2021
Ani Pharmaceuticals, Inc.3granule, for suspensionGeneric drugs (ANDA)March 25, 2019
Asclemed USA, Inc.3ointmentGeneric drugs (ANDA)May 8, 2014
Bryant Ranch Prepack3gel; swabGeneric drugs (ANDA)July 7, 2008
Padagis Israel Pharmaceuticals Ltd3gel; swabGeneric drugs (ANDA)December 19, 2011
Alembic Pharmaceuticals Inc.2tablet, film coatedGeneric drugs (ANDA)August 28, 2023
Alembic Pharmaceuticals Limited2tablet, film coatedGeneric drugs (ANDA)August 28, 2023
Amneal Pharmaceuticals NY LLC2suspensionGeneric drugs (ANDA)December 2, 2023
Armas Pharmaceuticals Inc.2injection, powder, lyophilized, for solution; ointmentGeneric drugs (ANDA)July 9, 2026
Ascend Laboratories, LLC2tablet, film coatedGeneric drugs (ANDA)July 14, 2022
Kanchan Healthcare Inc2for suspensionGeneric drugs (ANDA)November 21, 2022
Modavar Pharmaceuticals LLC2tablet, film coatedGeneric drugs (ANDA)July 31, 2021
Nivagen Pharmaceuticals, Inc.2suspensionGeneric drugs (ANDA)February 1, 2023
Orange Pharmaceuticals USA LLC2tablet, film coatedGeneric drugs (ANDA)October 5, 2019
Proficient Rx LP2ointmentGeneric drugs (ANDA)July 18, 1996
Redpharm Drug2ointmentGeneric drugs (ANDA)April 1, 2026
Remedyrepack Inc.2ointment; tabletGeneric drugs (ANDA)June 23, 2026
Teva Pharmaceuticals USA, Inc.2tablet, film coatedGeneric drugs (ANDA)May 4, 2021
Zydus Lifesciences Limited2tablet, film coatedGeneric drugs (ANDA)June 30, 2023
Zydus Pharmaceuticals USA Inc.2tablet, film coatedGeneric drugs (ANDA)June 30, 2023
Bausch & Lomb Incorporated1ointmentGeneric drugs (ANDA)July 29, 1994
Cardinal Health 107, LLC1ointmentGeneric drugs (ANDA)July 29, 1994
Direct RX1ointmentGeneric drugs (ANDA)January 1, 2014
Dr. Reddy's Laboratories Inc.1capsule, delayed release pelletsAuthorized generics (NDA)September 1, 2024
Fera Pharmaceuticals, LLC1ointmentUnapproved drugs for a shortageSeptember 27, 2023
Gland Pharma Limited1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)November 19, 2024
Hospira, Inc.1injection, powder, lyophilized, for solutionNew drug applications (NDA)May 25, 2005
NuCare Pharmaceuticals, Inc.1ointmentGeneric drugs (ANDA)July 29, 1994
PD-Rx Pharmaceuticals, Inc.1tablet, film coatedGeneric drugs (ANDA)September 6, 2011
Piramal Critical Care Inc1injection, powder, for solutionGeneric drugs (ANDA)August 13, 2026
Preferred Pharmaceuticals Inc.1ointmentGeneric drugs (ANDA)April 2, 2015
Rising Pharma Holdings, Inc.1gelGeneric drugs (ANDA)October 18, 2016
Saptalis Pharmaceuticals, LLC.1solutionGeneric drugs (ANDA)August 14, 2024
Sentiss Pharmaceuticals LLC1ointmentGeneric drugs (ANDA)April 1, 2026
Sportpharm LLC1ointmentGeneric drugs (ANDA)July 29, 1994
St. Mary's Medical Park Pharmacy1ointmentGeneric drugs (ANDA)October 18, 2023

Dosage forms

Dosage formProductsShare
Tablet, film coated2422%
Ointment2321.1%
Tablet, delayed release1412.8%
Suspension109.2%
Granule, for suspension76.4%
For suspension65.5%
Gel54.6%
Solution43.7%
Tablet, coated43.7%
Injection, powder, lyophilized, for solution32.8%
Tablet32.8%
Swab32.8%

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.